サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1667742

製剤開発アウトソーシングの世界市場レポート 2025年

Formulation Development Outsourcing Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
製剤開発アウトソーシングの世界市場レポート 2025年
出版日: 2025年02月28日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

製剤開発アウトソーシング市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.4％で485億5,000万米ドルに成長します。予測期間の成長は、医薬品分子の複雑化、戦略的パートナーシップ、研究開発コストの上昇、バイオ医薬品のイノベーション、柔軟な生産能力などに起因すると考えられます。予測期間における主な動向としては、連続製造プロセスの統合、修正放出製剤のアウトソーシング、特殊なドラッグデリバリーシステムの共同開発、アウトソーシングサービスにおける規制に関する専門知識、製剤設計における人工知能（AI）の活用などが挙げられます。

慢性疾患の有病率の増加が、今後の製剤開発アウトソーシング市場の成長を牽引すると予想されます。慢性疾患は、継続的な医療を必要とし、日常生活を制限する可能性のある長期にわたる疾患です。これらの疾患に対する効果的な製剤や治療法の開発には、専門的な知識やリソースが必要となります。製剤開発アウトソーシングでは、慢性疾患の治療を目的とした製剤の研究開発・最適化を行うために、外部の専門家や専門企業と連携しています。例えば、2023年11月、ルクセンブルクの政府機関であるユーロスタットは、2022年にEUの個人の3分の1以上（36.1％）が長期の慢性的な健康状態に直面していると報告しました。そのため、慢性疾患の罹患率の上昇が製剤開発アウトソーシング市場の成長に拍車をかけています。

また、製剤開発アウトソーシング市場は医薬品需要の増加による成長も見込まれています。医薬品は、治療、疾病予防、症状緩和、娯楽目的で使用される物質であり、ヘルスケア産業の中心的存在です。製剤開発アウトソーシングは医薬品開発において重要な役割を果たしており、バイオ医薬品や新規ドラッグデリバリーシステムの開発などの活動をサポートし、医薬品開発プロセスを加速させ、製薬会社にコスト効率の高いソリューションを提供しています。2022年4月、フィアス・ヘルスケアによると、米国の医薬品支出総額は2021年に7.7%増の5,769億米ドルに達し、2022年には4%から6%増加すると予測されています。したがって、医薬品需要の拡大は、製剤開発アウトソーシング市場の成長を促進する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界製剤開発アウトソーシング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
  • 最終用途産業の分析
  • 世界の製剤開発アウトソーシング市場：成長率分析
  • 世界の製剤開発アウトソーシング市場の実績：規模と成長, 2019-2024
  • 世界の製剤開発アウトソーシング市場の予測：規模と成長, 2024-2029, 2034F
  • 世界製剤開発アウトソーシング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の製剤開発アウトソーシング市場：サービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 処方前
  • 処方開発
  • 世界の製剤開発アウトソーシング市場治療領域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 腫瘍学
  • 感染症
  • 神経学
  • 血液学
  • 呼吸器
  • 心臓血管
  • 皮膚科
  • その他の治療法
  • 世界の製剤開発アウトソーシング市場処方別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • オーラル
  • 注射可能
  • 話題
  • その他の処方
  • 世界の製剤開発アウトソーシング市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 製薬業界
  • 調査と学術開発
  • 世界の製剤開発アウトソーシング市場、タイプ別プレフォーミュレーションのサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 物理化学的特性評価
  • 安定性テスト
  • 製剤実現可能性調査
  • 分析法開発
  • 世界の製剤開発アウトソーシング市場、処方開発のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 医薬品製剤開発
  • プロセス開発
  • スケールアップと技術移転
  • 設計品質（QbD）開発

第7章 地域別・国別分析

  • 世界の製剤開発アウトソーシング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の製剤開発アウトソーシング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 製剤開発アウトソーシング市場：競合情勢
  • 製剤開発アウトソーシング市場：企業プロファイル
    • Syngene International Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Aizant Drug Research Solutions Private Limited. Overview, Products and Services, Strategy and Financial Analysis
    • Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Intertek Group plc Overview, Products and Services, Strategy and Financial Analysis
    • Recipharm AB Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • SGS S.A.
  • Lonza Group AG
  • Eurofins Scientific SE
  • Laboratory Corporation of America Holdings
  • Charles River Laboratories International Inc.
  • Emergent Biosolutions Inc.
  • IRISYS LLC
  • Piramal Pharma Limited.
  • Biocon Limited.
  • Dr Reddy's Laboratories Ltd.
  • Quotient Sciences Ltd.
  • Almac Group
  • Patheon
  • Evonik Industries AG
  • Metrics Contract Services

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 製剤開発アウトソーシング市場2029：新たな機会を提供する国
  • 製剤開発アウトソーシング市場2029：新たな機会を提供するセグメント
  • 製剤開発アウトソーシング市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r24153

Formulation development outsourcing involves the practice of enlisting external experts or organizations to manage the formulation and development process of a product. This outsourcing arrangement enables companies to tap into the specialized knowledge, resources, and expertise of external parties for the development or enhancement of their product formulations.

The primary services offered in formulation development outsourcing include pre-formulation and formulation development. Pre-formulation pertains to the developmental stage in pharmaceutical formulations, encompassing various therapeutic areas such as oncology, infectious disease, neurology, hematology, respiratory, cardiovascular, dermatology, among others. These formulations cover diverse administration methods, including oral, injectable, topical, and others. Formulation development outsourcing is utilized by various end-users, including pharmaceutical industries, research entities, and academic development.

The formulation development outsourcing research report is one of a series of new reports from The Business Research Company that provides formulation development outsourcing statistics, including formulation development outsourcing industry global market size, regional shares, competitors with a formulation development outsourcing share, detailed formulation development outsourcing segments, market trends, and opportunities, and any further data you may need to thrive in the formulation development outsourcing industry. This formulation development outsourcing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The formulation development outsourcing market size has grown strongly in recent years. It will grow from$29.83 billion in 2024 to $32.62 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to cost efficiency, focus on core competencies, regulatory compliance, accelerated drug development, and access to specialized expertise

The formulation development outsourcing market size is expected to see rapid growth in the next few years. It will grow to $48.55 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to the increased complexity of drug molecules, strategic partnerships, rising R&D costs, biopharmaceutical innovations, and flexible capacity. Major trends in the forecast period include integration of continuous manufacturing processes, outsourcing for modified-release formulations, collaborations for specialized drug delivery systems, regulatory expertise in outsourced services, and utilization of artificial intelligence (AI) in formulation design.

The increasing prevalence of chronic diseases is expected to drive the growth of the formulation development outsourcing market in the future. Chronic diseases are long-lasting conditions that require ongoing medical care and can limit daily activities. Developing effective formulations and therapies for these conditions demands specialized expertise and resources. Formulation development outsourcing involves collaborating with external experts or specialized companies to handle the research, development, and optimization of drug formulations aimed at treating chronic diseases. For example, in November 2023, Eurostat, a government agency in Luxembourg, reported that over one-third (36.1%) of individuals in the EU faced a long-term chronic health condition in 2022. Therefore, the rising incidence of chronic diseases is fueling the growth of the formulation development outsourcing market.

The formulation development outsourcing market is also expected to witness growth due to the increasing demand for drugs. Drugs, substances used for medical treatment, disease prevention, symptom relief, or recreational purposes, are central to the healthcare industry. Formulation development outsourcing plays a crucial role in drug development, supporting activities such as the development of biopharmaceuticals and novel drug delivery systems, accelerating the drug development process, and providing a cost-effective solution for pharmaceutical companies. In April 2022, according to Fierce Healthcare, total drug expenditure in the United States witnessed a 7.7% growth in 2021, reaching $576.9 billion, and is projected to experience an estimated increase ranging from 4% to 6% in 2022. Therefore, the growing demand for drugs is a significant factor driving the growth of the formulation development outsourcing market.

Technological advancements represent a prominent trend gaining traction in the formulation development outsourcing market. Companies within this market are embracing cutting-edge technologies, such as artificial intelligence (AI) and machine learning (ML), to maintain their competitive positions. For example, in March 2023, Nvidia, a US-based software technology company, introduced BioNeMo Cloud, a novel component in their AI Foundations suite. This service grants researchers access to pre-trained AI models, facilitating customization with private data to expedite life sciences research, drug discovery, and protein engineering. Notably, industry leaders such as Amgen and numerous startups are leveraging this technology as a cloud service, accelerating drug development processes.

Major players in the formulation development outsourcing market are strategically focusing on enhancing various outsourcing capabilities, including method development. Method development capabilities denote an organization's or laboratory's expertise, skills, and resources to create, optimize, and validate analytical methods for analyzing various substances. For instance, in February 2022, Berkshire Sterile Manufacturing (BSM), a US-based sterile filling contract manufacturer, bolstered its clients' drug production capabilities by incorporating formulation, lyophilization, and method development expertise. BSM is expanding its services to cover first-in-human formulation development, providing materials for preclinical studies, and conducting research-level stability studies. Additionally, BSM is offering services for formulation optimization, process development, optimization, and scale-up studies, utilizing materials and equipment indicative of future Good Manufacturing Practice (GMP) manufacturing.

In August 2022, Catalent Inc., a US-based pharmaceutical company, completed the acquisition of Metrics Inc. for $475 million. This strategic move broadened, diversified, and enriched Catalent's portfolio by adding capabilities in integrated oral solid formulation development, manufacturing, and packaging. This expansion aims to assist customers in simplifying and accelerating their programs while enhancing their capacity to handle highly potent compounds. Metrics Inc. is a US-based global pharmaceutical formulation development organization specializing in novel oral dosage forms.

Major companies operating in the formulation development outsourcing market include Syngene International Ltd., Aizant Drug Research Solutions Private Limited., Catalent Inc., Intertek Group plc, Recipharm AB, SGS S.A., Lonza Group AG, Eurofins Scientific SE, Laboratory Corporation of America Holdings, Charles River Laboratories International Inc., Emergent Biosolutions Inc., IRISYS LLC, Piramal Pharma Limited., Biocon Limited., Dr Reddy's Laboratories Ltd., Quotient Sciences Ltd., Almac Group, Patheon, Evonik Industries AG, Metrics Contract Services, Aenova Group, Fareva Group, Vetter Pharma International GmbH, Aesica Pharmaceuticals, WuXi AppTec, Formosa Laboratories Inc., Aptuit LLC, ProPharma Group, Laurus Labs Limited

North America was the largest region in the global formulation development outsourcing market in 2024. The regions covered in the formulation development outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the formulation development outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The formulation development outsourcing market includes revenues earned by entities by providing services such as ingredient sourcing, stability studies, analytical testing, and regulatory support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Formulation Development Outsourcing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on formulation development outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for formulation development outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The formulation development outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Service: Preformulation, Formulation Development
  • 2) By Therapeutic Area: Oncology, Infectious Disease, Neurology, Hematology, Respiratory, Cardiovascular, Dermatology, Other Therapeutics
  • 3) By Formulation: Oral, Injectable, Topical, Other Formulations
  • 4) By End-User: Pharmaceutical Industries, Research And Academic Development
  • Subsegments:
  • 1) By Preformulation: Physicochemical Characterization; Stability Testing; Formulation Feasibility Studies; Analytical Method Development
  • 2) By Formulation Development: Drug Formulation Development; Process Development; Scale-Up And Technology Transfer; Quality By Design (QbD) Development
  • Companies Mentioned: Syngene International Ltd.; Aizant Drug Research Solutions Private Limited.; Catalent Inc.; Intertek Group plc; Recipharm AB
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Formulation Development Outsourcing Market Characteristics

3. Formulation Development Outsourcing Market Trends And Strategies

4. Formulation Development Outsourcing Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Formulation Development Outsourcing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Formulation Development Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Formulation Development Outsourcing Market Growth Rate Analysis
  • 5.4. Global Formulation Development Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Formulation Development Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Formulation Development Outsourcing Total Addressable Market (TAM)

6. Formulation Development Outsourcing Market Segmentation

  • 6.1. Global Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Preformulation
  • Formulation Development
  • 6.2. Global Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Infectious Disease
  • Neurology
  • Hematology
  • Respiratory
  • Cardiovascular
  • Dermatology
  • Other Therapeutics
  • 6.3. Global Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Injectable
  • Topical
  • Other Formulations
  • 6.4. Global Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical Industries
  • Research And Academic Development
  • 6.5. Global Formulation Development Outsourcing Market, Sub-Segmentation Of Preformulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Physicochemical Characterization
  • Stability Testing
  • Formulation Feasibility Studies
  • Analytical Method Development
  • 6.6. Global Formulation Development Outsourcing Market, Sub-Segmentation Of Formulation Development, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Formulation Development
  • Process Development
  • Scale-Up And Technology Transfer
  • Quality By Design (QbD) Development

7. Formulation Development Outsourcing Market Regional And Country Analysis

  • 7.1. Global Formulation Development Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Formulation Development Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Formulation Development Outsourcing Market

  • 8.1. Asia-Pacific Formulation Development Outsourcing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Formulation Development Outsourcing Market

  • 9.1. China Formulation Development Outsourcing Market Overview
  • 9.2. China Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Formulation Development Outsourcing Market

  • 10.1. India Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Formulation Development Outsourcing Market

  • 11.1. Japan Formulation Development Outsourcing Market Overview
  • 11.2. Japan Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Formulation Development Outsourcing Market

  • 12.1. Australia Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Formulation Development Outsourcing Market

  • 13.1. Indonesia Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Formulation Development Outsourcing Market

  • 14.1. South Korea Formulation Development Outsourcing Market Overview
  • 14.2. South Korea Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Formulation Development Outsourcing Market

  • 15.1. Western Europe Formulation Development Outsourcing Market Overview
  • 15.2. Western Europe Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Formulation Development Outsourcing Market

  • 16.1. UK Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Formulation Development Outsourcing Market

  • 17.1. Germany Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Formulation Development Outsourcing Market

  • 18.1. France Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Formulation Development Outsourcing Market

  • 19.1. Italy Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Formulation Development Outsourcing Market

  • 20.1. Spain Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Formulation Development Outsourcing Market

  • 21.1. Eastern Europe Formulation Development Outsourcing Market Overview
  • 21.2. Eastern Europe Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Formulation Development Outsourcing Market

  • 22.1. Russia Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Formulation Development Outsourcing Market

  • 23.1. North America Formulation Development Outsourcing Market Overview
  • 23.2. North America Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Formulation Development Outsourcing Market

  • 24.1. USA Formulation Development Outsourcing Market Overview
  • 24.2. USA Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Formulation Development Outsourcing Market

  • 25.1. Canada Formulation Development Outsourcing Market Overview
  • 25.2. Canada Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Formulation Development Outsourcing Market

  • 26.1. South America Formulation Development Outsourcing Market Overview
  • 26.2. South America Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Formulation Development Outsourcing Market

  • 27.1. Brazil Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Formulation Development Outsourcing Market

  • 28.1. Middle East Formulation Development Outsourcing Market Overview
  • 28.2. Middle East Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Formulation Development Outsourcing Market

  • 29.1. Africa Formulation Development Outsourcing Market Overview
  • 29.2. Africa Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Formulation Development Outsourcing Market Competitive Landscape And Company Profiles

  • 30.1. Formulation Development Outsourcing Market Competitive Landscape
  • 30.2. Formulation Development Outsourcing Market Company Profiles
    • 30.2.1. Syngene International Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Aizant Drug Research Solutions Private Limited. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Intertek Group plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Recipharm AB Overview, Products and Services, Strategy and Financial Analysis

31. Formulation Development Outsourcing Market Other Major And Innovative Companies

  • 31.1. SGS S.A.
  • 31.2. Lonza Group AG
  • 31.3. Eurofins Scientific SE
  • 31.4. Laboratory Corporation of America Holdings
  • 31.5. Charles River Laboratories International Inc.
  • 31.6. Emergent Biosolutions Inc.
  • 31.7. IRISYS LLC
  • 31.8. Piramal Pharma Limited.
  • 31.9. Biocon Limited.
  • 31.10. Dr Reddy's Laboratories Ltd.
  • 31.11. Quotient Sciences Ltd.
  • 31.12. Almac Group
  • 31.13. Patheon
  • 31.14. Evonik Industries AG
  • 31.15. Metrics Contract Services

32. Global Formulation Development Outsourcing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Formulation Development Outsourcing Market

34. Recent Developments In The Formulation Development Outsourcing Market

35. Formulation Development Outsourcing Market High Potential Countries, Segments and Strategies

  • 35.1 Formulation Development Outsourcing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Formulation Development Outsourcing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Formulation Development Outsourcing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer